Michaela Scherr

Michaela Scherr

Auto-generated profile, based on publicly available information

Michaela Scherr

Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2003 in Blood
Verified
Journal Article
Open access
PDF file
MSMichaela Scherr
Michaela Scherr
KBKarin Battmer
Karin Battmer
TWThomas Winkler
Thomas Winkler
OHOlaf Heidenreich
Olaf Heidenreich
AGArnold Ganser
Arnold Ganser
MEMatthias Eder
Matthias Eder
Small interfering RNAs (siRNAs) were designed to target thebcr-abl oncogene, which causes chronic myeloid leukemia (CML) and bcr-abl–positive acute lymphoblastic leukemia (ALL). Chemically synthesized anti–bcr-abl siRNAs were selected using reporter gene constructs and were found to reduce bcr-abl mRNA up to 87% in bcr-abl–positive cell lines and in primary cells from CML patients. This mRNA reduction was specific for bcr-abl because c-abl and c-bcr mRNA levels remained unaffected. Furthermore, protein expression of BCR-ABL and of laminA/C was reduced by specific siRNAs up to 80% in bcr-abl–positive and normal CD34+ cells, respectively. Finally, anti–bcr-abl siRNA inhibited BCR-ABL–dependent, but not cytokine-dependent, proliferation in a bcr-abl–positive cell line. These data demonstrate that siRNA can specifically and efficiently interfere with the expression of an oncogenic fusion gene in hematopoietic cells.

19 November 2007 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MSMichaela Scherr
Michaela Scherr
LVLetizia Venturini
Letizia Venturini
KBKarin Battmer
Karin Battmer
MSMichael Schaller-Schoenitz
Michael Schaller-Schoenitz
DSDaniel Schaefer
Daniel Schaefer
MEMatthias Eder
Matthias Eder
Micro RNAs (miRNA) regulate gene expression by hybridization and recruitment of multi-protein complexes to complementary mRNA target sequences. miRNA function can transiently be antagonized by antagomirs—chemically modified oligonucleotides complementary to individual miRNAs. Here, we describe the induction of stable loss-of-function phenotypes for specific miRNAs by lentivirus-mediated antagomir expression. Lentivirally expressed antagomirs are transcribed from a H1-promoter located within the lentiviral 3′LTR and were directed against miRNAs encoded on the polycistronic miR17-92 transcript. Functional silencing of miR-18a, miR-19b and miR-20a by the corresponding antagomirs specifically relieves miRNA-mediated reporter gene repression. Inhibition of miRNA function correlates to reduction of ‘miRNA’ amplification by miRNA-specific quantitative RT-PCR. Furthermore, protein expression of E2F-1, a known miR-20 target, is enhanced by lentivirally expressed anti-miR-20 antagomirs in a dose-dependent manner, whereas over-expression of miR-20a reduces E2F-1 levels. Finally, combined over-expression of specific miRNAs and antagomirs reveals individual and complementary functions of miR-18a and miR-20a and demonstrates specific miRNA impact on cell proliferation in a cell culture model.

1 February 2003 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
MSMichaela Scherr
Michaela Scherr
MMMichael A. Morgan
Michael A. Morgan
MEMatthias Eder
Matthias Eder
RNA interference (RNAi) as a protecting mechanism against invasion by foreign genes was first described in C. elegans and has subsequently been demonstrated in diverse eukaryotes such as insects, plants, fungi and vertebrates. RNAi is the mechanism of sequence-specific, post-transcriptional gene silencing initiated by double-stranded RNAs (dsRNA) homologous to the gene being suppressed. dsRNAs are processed by Dicer, a cellular ribonuclease III, to generate duplexes of about 21 nt with 3-overhangs (small interfering RNA, siRNA) which mediate sequence-specific mRNA degradation. In mammalian cells siRNA molecules are capable of specifically silencing gene expression without induction of the unspecific interferon response pathway. Thus, siRNAs have become a new and powerful alternative to other genetic tools such as antisense oligonucleotides and ribozymes to analyze loss-of-function phenotypes. Application of siRNA duplexes to interfere with the expression of a specific gene requires knowledge of target accessibility, highly effective delivery of siRNAs into target cells and for some applications long-term siRNA expression. Effective strategies to deliver siRNAs to target cells in cell culture include transduction by physical or chemical transfection. An alternative strategy uses the endogenous expression of siRNAs by various Pol III promoter expression cassettes that allow transcription of functional siRNAs or their precursors. This review summarizes some genetic and biochemical aspects of RNAi, the delivery and application of siRNAs to target cells, the kinetics of RNAi and the utility of siRNAs as analytical and potential therapeutic tools.

15 February 2007 in Cell Cycle
Verified
Journal Article
Closed access
PDF file
MSMichaela Scherr
Michaela Scherr
MEMatthias Eder
Matthias Eder
Since some years, activation of RNA interference (RNAi) has been developed into a widely used and powerful biological tool to functionally annotate genomes. Several variants of small regulatory RNAs can trigger this evolutionary highly conserved cellular pathway leading to specific hybridisation to and subsequent degradation or translational repression of target mRNAs. These regulatory RNAs include synthetic double-stranded small interfering RNAs (siRNAs), pol III transcribed small hairpin RNAs (shRNAs), or endogenous or artificial micro RNAs (miRNAs) which are expressed from pol II promoters as primary pri-miRNA transcripts subsequently processed into mature miRNAs in a regulated multi-step process. Depending on the mode of activation RNA-processing and efficacy as well as kinetics of RNAi may differ from transient effects to long-lasting gene silencing. However, one of the major challenges for in vitro and in vivo application of RNAi still remains the efficient delivery of suitable RNAi-triggers to target cells. This review highlights the mechanism of RNAi and its activation, the use of plasmid-based and retro-/ lentiviral vector-based systems to mediate long-term RNAi, kinetic aspects of RNAi and their impact on selection of cell populations with modified gene expression.

15 April 2006 in Blood
Verified
Journal Article
Closed access
PDF file
MSMichaela Scherr
Michaela Scherr
ACAnuhar Chaturvedi
Anuhar Chaturvedi
KBKarin Battmer
Karin Battmer
IDIris Dallmann
Iris Dallmann
BSBeate Schultheis
Beate Schultheis
MEMatthias Eder
Matthias Eder
Although targeting the BCR-ABL tyrosine kinase activity by imatinib mesylate has rapidly become first-line therapy in chronic myeloid leukemia (CML), drug resistance suggests that combination therapy directed to a complementing target may significantly improve treatment results. To identify such potential targets, we used lentivirus-mediated RNA interference (RNAi) as a tool for functional genomics in cell lines as well as primary normal and CML CD34+ cells. In a conditional cell culture model, we demonstrate that RNAi-mediated reduction of SHP2, STAT5, and Gab2 protein expression inhibits BCR-ABL-dependent but not cytokine-dependent proliferation in a dose-dependent manner. Similarly, colony formation of purified primary CML but not of normal CD34+ colony-forming cells is specifically reduced by inhibition of SHP2, STAT5, and Gab2 expression, respectively. In addition, coexpression of both anti-BCR-ABL and anti-SHP2 shRNAs from a single lentiviral vector induces stronger inhibition of colony formation as compared to either shRNA alone. The data indicate that BCR-ABL expression may affect the function of normal signaling molecules. Targeting these molecules may harbor significant therapeutic potential for the treatment of patients with CML.

29 May 2003 in Cell Cycle
Verified
Journal Article
Closed access
MSMichaela Scherr
Michaela Scherr
KBKarin Battmer
Karin Battmer
AGArnold Ganser
Arnold Ganser
MEMatthias Eder
Matthias Eder
RNA interference (RNAi) mediates sequence-specific posttranscriptional gene silencing triggered by double-stranded RNA. RNAi is an effective tool for functional genomics in C. elegans, whereas bioc...